New-onset atrial fibrillation complicates 2.8% to 58% of acute myocardial infarctions treated with primary PCI and is associated with increased short- and long-term mortality and morbidity.
Systematic Review
Does new-onset atrial fibrillation worsen outcomes in patients with acute myocardial infarction treated with primary PCI?
New-onset atrial fibrillation is a common complication after primary PCI for acute myocardial infarction and serves as an adverse prognostic marker for increased mortality and morbidity.
Abstract Background: Atrial fibrillation is a relatively common complication of acute myocardial infarction with significant impact on the short and long-term prognosis. Methods: A systematic literature review was done through Pubmed and CENTRAL to extract data related to new-onset atrial fibrillation following primary PCI. Results: Searching resulted in twenty-one matched studies. Extraction of data showed an incidence rate of new-onset atrial fibrillation (2.8%-58%). A negative impact was found on the outcomes of patients treated with primary PCI with increased short and long-term mortality and morbidity. Conclusion: New-onset atrial fibrillation is an adverse prognostic marker in patients with acute myocardial infarction treated invasively. Preventive measures and anticoagulant therapy should be considered more intensively in this subset of patients.
AL-Obaidi et al. (Wed,) conducted a systematic review in Acute myocardial infarction treated with primary PCI. New-onset atrial fibrillation vs. No atrial fibrillation was evaluated on Incidence of new-onset atrial fibrillation and its impact on mortality and morbidity. New-onset atrial fibrillation complicates 2.8% to 58% of acute myocardial infarctions treated with primary PCI and is associated with increased short- and long-term mortality and morbidity.